Publicação
Therapeutic approach for Covid-19 patients
| dc.contributor.author | Saldanha, Carlota | |
| dc.date.accessioned | 2022-05-10T13:58:35Z | |
| dc.date.available | 2022-05-10T13:58:35Z | |
| dc.date.issued | 2020 | |
| dc.description | Copyright © All rights are reserved by Carlota Saldanha. This work is licensed under Creative Commons Attribution 4.0 License | pt_PT |
| dc.description.abstract | The biochemical effects of hydroxychloroquine, ivermectin, azithromycin molecules, and the zinc cation on functional properties of human erythrocyte will be presented. Among a wide range of therapeutically applications attributed to hydroxycloroquine the anti-inflammatory role will be herein highlight as well as for the azithromycin. The intervention of the ivermectin molecules into cell abortion mechanism of the virus replication will be described. The action of hydroxychloroquine, ivermectin, azithromycin molecules, and of zinc cation to prevent the spread and the replication SARS2-CoV2 Virus, as a first therapeutic approach for Covid-19 symptomatic patients, will be the aim of the present opinion. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Nov Appro Drug Des Dev. 2020; 5(3): 555664 | pt_PT |
| dc.identifier.doi | 10.19080/NAPDD.2020.05.555664 | pt_PT |
| dc.identifier.issn | 2575-8942 | |
| dc.identifier.uri | http://hdl.handle.net/10451/52847 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Juniper Publishers | pt_PT |
| dc.relation.publisherversion | https://juniperpublishers.com/napdd/ | pt_PT |
| dc.relation.publisherversion | https://juniperpublishers.com/napdd/NAPDD.MS.ID.555664.php | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Erythrocyte acethylcholinesterase receptor | pt_PT |
| dc.subject | Hydroxycloroquine | pt_PT |
| dc.subject | Azithromycin | pt_PT |
| dc.subject | Ivermectin | pt_PT |
| dc.subject | Zinc cation | pt_PT |
| dc.title | Therapeutic approach for Covid-19 patients | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 060 | pt_PT |
| oaire.citation.issue | 3 | pt_PT |
| oaire.citation.startPage | 058 | pt_PT |
| oaire.citation.title | Novel Approaches in Drug Designing & Development | pt_PT |
| oaire.citation.volume | 5 | pt_PT |
| person.familyName | Saldanha | |
| person.givenName | Carlota | |
| person.identifier | 53901 | |
| person.identifier.orcid | 0000-0002-5058-2112 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | ad6de30c-87ca-4613-bb87-488dd5d285d0 | |
| relation.isAuthorOfPublication.latestForDiscovery | ad6de30c-87ca-4613-bb87-488dd5d285d0 |
Ficheiros
Principais
1 - 1 de 1
